• Proactive - Interviews for investors

  • By: Proactive
  • Podcast

Proactive - Interviews for investors By cover art

Proactive - Interviews for investors

By: Proactive
Listen for free

  • Summary

  • Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.
    Show more Show less
activate_primeday_promo_in_buybox_DT
Episodes
  • Tonix Pharmaceuticals Awarded potential 34 million dollar Contract with U.S. Department of Defence

    Tonix Pharmaceuticals Awarded potential 34 million dollar Contract with U.S. Department of Defence
    Jul 19 2024
    Tonix Pharmaceuticals CEO Dr. Seth Lederman joined Steve Darling from Proactive to share exciting news about a significant achievement for the company. Tonix Pharmaceuticals has been awarded a potential contract worth up to $34 million over five years by the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense. This contract aims to develop small molecule broad-spectrum antiviral agents for the prevention or treatment of infections, thereby enhancing the medical readiness of military personnel in biological threat environments. Dr. Lederman explained that Tonix’s program will concentrate on the optimization and development of its TNX-4200 program. The goal is to develop an orally available CD45 antagonist with broad-spectrum efficacy against various viral families through extensive preclinical evaluation. The program is expected to establish essential physicochemical properties, pharmacokinetics, and safety attributes to support an Investigational New Drug (IND) submission, ultimately funding a first-in-human Phase 1 clinical study. The agreement with DTRA is a strategic move to address the DoD’s objective of protecting U.S. Joint Forces from potential biological weapon threats. The DoD announced in December 2022 that it aims to move beyond the traditional ‘one bug, one drug’ approach and is seeking broad-spectrum drugs, as predicting which viruses or how many may be deployed in a biological threat scenario is challenging. Dr. Lederman emphasized that the collaboration with DTRA underscores Tonix Pharmaceuticals' commitment to advancing medical readiness and protection for military personnel. By developing a broad-spectrum antiviral agent, Tonix aims to provide a versatile and robust solution to potential viral threats, enhancing the preparedness and resilience of the U.S. military in diverse and unpredictable biological threat environments. The TNX-4200 program’s focus on creating an effective, orally available antiviral agent highlights Tonix’s innovative approach to addressing complex medical challenges. The successful development of this broad-spectrum antiviral could significantly impact the way viral infections are managed in military and potentially civilian populations, offering a proactive measure against a wide array of viral threats. Tonix Pharmaceuticals continues to be at the forefront of medical innovation, dedicated to developing cutting-edge solutions that meet the evolving needs of the healthcare and defense sectors. The support from the DoD through this substantial contract is a testament to the potential and importance of Tonix’s TNX-4200 program in safeguarding the health and readiness of military personnel against biological threats. #proactiveinvestors #tonixpharmaceuticalsholdingcorp #nasdaq #tnxp #BroadSpectrumAntiviral, #USDepartmentOfDefense, #BiologicalWarfare, #DrugDevelopment, #ImmuneSystem, #SyntheticBiology, #VirusResearch, #InfectiousDisease, #R&D, #FrederickMaryland, #PharmaceuticalInnovation, #HealthcareTechnology, #Biotech, #MedicalResearch, #DefenseContract, #AntiviralAgent, #Healthcare, #PandemicPreparedness, #ScientificResearch#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    5 mins
  • Regency Silver Corp Announces $2.5 Million Financing to Advance Dios Padre Drilling Program

    Regency Silver Corp Announces $2.5 Million Financing to Advance Dios Padre Drilling Program
    Jul 19 2024
    Regency Silver Corp Executive Chairman Bruce Bragagnolo joined Steve Darling from Proactive to announce that the company has successfully arranged a non-brokered private placement, subject to regulatory approval, for gross proceeds of up to 2.5 million dollars. This significant financing effort underscores the company's commitment to advancing its exploration activities. Bragagnolo expressed the company's excitement about continuing their drilling program at the Dios Padre project. The drill crew is set to mobilize immediately upon the closure of this financing round. He highlighted that the drilling results to date have been promising, indicating the presence of a high-grade, high-sulphidation gold-copper-silver system that is proximal to a porphyry source. Previous drill results have been particularly encouraging. Hole REG-23-21 intersected 54.65 meters of 5.34 g/t gold, including a notable 7.36 g/t over 38 meters in a 65-meter step-out along strike to the southeast from the discovery hole REG-22-01. The discovery hole itself had returned impressive figures of 35.8 meters of 6.84 g/t gold, 0.88% copper, and 21.82 g/t silver. Additionally, Hole REG-23-14 intersected 35.9 meters of 5.51 g/t gold. These results continue to bolster Regency Silver Corp's confidence in the Dios Padre project's potential. The company is poised to further explore and validate this promising high-grade mineralization system, aiming to capitalize on its substantial economic potential. The successful completion of this financing will enable Regency Silver Corp to advance its drilling activities and continue generating value for its shareholders. #proactiveinvestors #regencysilvercorp #tsxv #otcqb #esmx #gold #silver #BruceBragagnolo, #PrivatePlacement, #GoldExploration, #AdiosPadreProject, #HighGradeGold, #CopperGoldPorphyry, #DrillingResults, #MiningInvestment, #GoldMarket, #MetalsPrices, #JuniorSectorMining, #CapitalRaise, #ExplorationFunding, #DrillingProjects, #MiningIndustry, #GoldPriceRise, #MineralExploration, #ResourceDevelopment, #MiningNews#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    3 mins
  • Bitcoin rides the 'Trump Trade', shrugs of Microsoft Crowdstrike IT outage - Crypto Roundup

    Bitcoin rides the 'Trump Trade', shrugs of Microsoft Crowdstrike IT outage - Crypto Roundup
    Jul 19 2024
    Proactive's Billy Farrington looks at significant developments impacting Bitcoin and the broader crypto market. A key topic discussed was the assassination attempt on presidential nominee Donald Trump, which led to a notable economic reaction. Dubbed the "Trump trade," this event caused a surge in Bitcoin's value, attributed to Trump's pro-crypto stance. Bitcoin saw a 12% increase, trading around $63,100, despite some midweek declines. Farrington noted the uncertainty surrounding the Democratic Party, with increasing calls for President Biden to step aside, potentially affecting Trump's chances and thus the Bitcoin market. Additionally, a major IT blackout affecting global airlines, Microsoft systems, and other services was highlighted. This incident underscored Bitcoin's resilience due to its decentralised nature, as it remained unaffected. Farrington suggested this event might strengthen the narrative around Bitcoin's robustness and decentralisation benefits. #Bitcoin, #CryptoNews, #DonaldTrump, #AssassinationAttempt, #TrumpTrade, #ProCrypto, #Decentralization, #Blockchain, #BTC, #CryptoMarket, #ITBlackout, #CyberSecurity, #Microsoft, #CrowdStrike, #GlobalMarkets, #PoliticalImpact, #Election2024, #CryptoResilience, #BitcoinRally, #ProactiveInvestors #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    7 mins
Business & Careers Economics Personal Finance Politics & Government
Show more Show less

What listeners say about Proactive - Interviews for investors

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available